Triamterene And Hydrochlorothiazide

   
Google
 
Web NewDrugInformation.com

Triamterene And Hydrochlorothiazide


Drug - Triamterene And Hydrochlorothiazide
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Triamterene
Multiple ingredients are in alphabetical order.

Strength - 25MG;37.5MG
The potency of the active ingredient(s), Hydrochlorothiazide; Triamterene. May repeat for multiple part products.

Applicant - BARR
The firm name holding legal responsibility for Triamterene And Hydrochlorothiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 071251
The FDA assigned number to Triamterene And Hydrochlorothiazide. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Triamterene And Hydrochlorothiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 5, 1998
The date Triamterene And Hydrochlorothiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Triamterene And Hydrochlorothiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Triamterene And Hydrochlorothiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Triamterene And Hydrochlorothiazide.

Triamterene And Hydrochlorothiazide